Britta M Jacobsen

4PUBLICATIONS
14CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 28, 2023
Riluzole Suppresses Growth and Enhances Response to Endocrine Therapy in ER+ Breast Cancer.

Ayodeji O Olukoya, Hillary Stires, Shaymaa Bahnassy

|Nov 13, 2020
Steroid Hormone Receptor and Infiltrating Immune Cell Status Reveals Therapeutic Vulnerabilities of ESR1-Mutant Breast Cancer.

Michelle M Williams, Nicole S Spoelstra, Spencer Arnesen

|Oct 24, 2020
Exogenous Thyroid Hormone Is Associated with Shortened Survival and Upregulation of High-Risk Gene Expression Profiles in Steroid Receptor-Positive Breast Cancers.

Reema S Wahdan-Alaswad, Susan M Edgerton, Hiba Salem

|Oct 15, 2018
Mucin 2 (MUC2) modulates the aggressiveness of breast cancer.

Anna Astashchanka, Thomas M Shroka, Britta M Jacobsen

Pageof 1